Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Comment by MikeyHon Sep 01, 2020 9:56am

108 Views

Post# 31485822

RE:RE:RE:100% specificity and selectivity in assymptomatics

No, my comment is accurate. Recording a negative result on 37 individuals without symptoms who are actually COVID-19 negative should be a given. Just like if you run water down the test it should come back as negative. I would be worried if 100% wasn't achieved.

Picking up positive cases is hugely challenging. They have managed it on a tiny sample size (which, don't get me wrong, is fantastic news) but statistically will need to improve this dataset.

Bullboard Posts

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity